Placebo Data Analysis in Alzheimer’s Diseases/Mild Cognitive Impairment


At a Glance
  • Status: Completed Consortium
  • Year Launched: 2009
  • Initiating Organization: Foundation for the National Institutes of Health
  • Initiator Type: Nonprofit foundation
  • Disease focus:
    Alzheimer's Disease
  • Location: North America

Abstract

The Placebo Data Analysis in Alzheimer’s Diseases/Mild Cognitive Impairment (PDA) consortium aims to combine placebo data from large clinical trials provided by multiple pharmaceutical companies with the original goal of creating datasets of 3,000 to 5,000 subjects for Alzheimer's disease (AD) and mild cognitive impairment (MCI) groups. The long-term goal is to develop better measures of disease progression -- outcome measures that have both low variability and are sensitive to change -- for use in future clinical trials.

Mission

In 2010, the Biomarkers Consortium launched the "Placebo Data Analysis in Alzheimer's Disease and Mild Cognitive Impairment Clinical Trials" consortium to pursue two specific goals: 1) collect the placebo arm data from the key multicenter clinical trials conducted by pharmaceutical and biotechnology companies and academia over the past 20 years of Alzheimer’s Diseases/Mild Cognitive Impairment research, and 2) to conduct statistical analysis of the pooled data to address a number of open questions in AD trial design, including characterizing progression over multiple domains, instrument refinement, prognostic factor detection, and providing insight into dropout patterns.

Sponsors & Partners

The Foundation for the National Institutes of Health will manage and administer this project. Principal Investigators are Marilyn Albert, Ron Petersen, Paul Aisen, Ronald Thomas. Project Chair is Maria Carrillo.

Homepage

http://www.fnih.org/work/research-partners/placebo-data-analysis-project-alzheimers-diseasemild-cognitive-impairment

Foundation for the National Institutes of Health


Last Updated: 04/08/2016

The Consortia-pedia Catalogue is a living resource, and we are always adding new consortia. Provide information here about your collaboration to apply to be included in the Catalogue.

All the information contained in the Consortia-pedia was collected from publically available sources. Decisions to include or exclude a particular listing from Consortia-pedia were also made on the basis of publically available information and the criteria outlined in the FAQs. This site is intended to be an objective resource for the community, and inclusion does not constitute or imply endorsement, recommendation, or approval by FasterCures or the Milken Institute.